Expedited Access to Biosimilars Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 9661.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. LANGWORTHY, as printed in the Congressional Record (Vol. 172, No. 114, July 14, 2026, Page H4467):
  Article I Section 8 of the Unites States Constitution
  Source: Congress.gov, Congressional Record July 14, 2026 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  53 characters

  Congress.gov bill record

  H.R. 9661, 119th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/119/hr/9661

  Record last updated by Congress.gov

  July 31, 2026

  PORKER copy retrieved

  September 13, 2026

  Stored copy, SHA-256 of the file

  e91a2f2fcb932afefecd7e9bec230364b8ea5e956c531403d24a1239727662b7

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of July 31, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 9661, last updated July 31, 2026. PORKER’s copy was retrieved September 13, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.